Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Myospots is an Australian healthcare company that develops and manufactures innovative tools for orofacial myofunctional therapy. The company's primary product is a small, flavored, dissolvable pad that adheres to the hard palate, serving as a sensory target to encourage correct tongue resting posture. By training the tongue to stay in the correct position on the roof of the mouth, Myospots helps patients transition from mouth breathing to nasal breathing and corrects tongue thrusting. Their products are utilized globally by orthodontists, speech therapists, and sleep specialists to treat conditions such as snoring, sleep-disordered breathing, and orthodontic instability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Myospots.